Gestational carrier in assisted reproductive technology

Fertil Steril. 2018 Mar;109(3):420-428. doi: 10.1016/j.fertnstert.2017.11.011. Epub 2018 Feb 7.

Abstract

Objective: To compare clinical outcomes of in vitro fertilization (IVF) cycles with the use of gestational carriers (GCs) with non-GC IVF cycles.

Design: Retrospective cohort study of assisted reproductive technology (ART) cycles performed with (24,269) and without (1,313,452) the use of a GC.

Setting: ART centers.

Patient(s): Infertile patients seeking IVF with or without use of a GC.

Interventions(s): Autologous and donor oocyte cycles, fresh and cryopreserved embryo transfer cycles.

Main outcome measure(s): Live birth rate (LBR), twin and high-order multiple birth rates.

Result(s): Approximately 2% of embryo transfers used a GC. Per embryo transfer, GCs had greater pregnancy rate and LBR across all IVF types compared with non-GC cycles in crude models and models adjusted a priori for potential confounders. For women with uterine-factor infertility, embryo transfer with the use of a GC resulted in a higher odds of live birth for autologous fresh embryos and for cryopreserved embryos compared with patients with non-uterine-factor infertility diagnoses.

Conclusion(s): GC benefits LBRs for some patients seeking ART. The highest LBRs occurred when the indication for GC was uterine-factor infertility.

Keywords: Gestational carrier; assisted reproductive technology; gestational surrogacy; in vitro fertilization.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Cryopreservation
  • Embryo Implantation
  • Embryo Transfer* / adverse effects
  • Female
  • Fertility
  • Fertilization in Vitro* / adverse effects
  • Humans
  • Infertility, Female / diagnosis
  • Infertility, Female / physiopathology
  • Infertility, Female / therapy*
  • Linear Models
  • Live Birth
  • Logistic Models
  • Male
  • Odds Ratio
  • Pregnancy
  • Pregnancy Rate
  • Pregnancy, Multiple
  • Retrospective Studies
  • Risk Factors
  • Surrogate Mothers*
  • Treatment Outcome